Beijing Sun-Novo Pharmaceutical Research Co. Ltd.SSE: 688621

2025 Semi-annual Report

Aug 29, 2025 · Issued by Beijing Sun-Novo Pharmaceutical Research Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 29, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-405

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix

Earlier from Beijing Sun-Novo Pharmaceutical Research

Announcement on Cancellation of Some Special Accounts for Raised FundsAug 20, 2025
Announcement on Progress in Trading for Planning to Issue Shares and Convertible Corporate Bonds to Purchase Assets and Raise Supporting Funds as well as Related Party TransactionsAug 9, 2025

Later from Beijing Sun-Novo Pharmaceutical Research

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Sep 16, 2025
Indicative Announcement on Equity Change by Controlling Shareholder and Persons Acting in ConcertSep 26, 2025
Voluntary Announcement on Extension of Affiliated Company's Plan to Purchase the Company's SharesOct 1, 2025
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4507Oct 13, 2025
Announcement on Convening Investor Briefing on Major Asset Restructuring MattersOct 14, 2025

All Beijing Sun-Novo Pharmaceutical Research news releases

Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.

Follow Beijing Sun-Novo Pharmaceutical Research